218 related articles for article (PubMed ID: 21943056)
21. Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads.
Dietze KK; Dittmer U; Koudaimi DK; Schimmer S; Reitz M; Breloer M; Hartmann W
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005170. PubMed ID: 27923052
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
23. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
24. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
[TBL] [Abstract][Full Text] [Related]
25. Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8
Knuschke T; Rotan O; Bayer W; Kollenda S; Dickow J; Sutter K; Hansen W; Dittmer U; Lang KS; Epple M; Buer J; Westendorf AM
Front Immunol; 2018; 9():614. PubMed ID: 29740425
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
[TBL] [Abstract][Full Text] [Related]
27. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
Schlecht-Louf G; Renard M; Mangeney M; Letzelter C; Richaud A; Ducos B; Bouallaga I; Heidmann T
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3782-7. PubMed ID: 20142478
[TBL] [Abstract][Full Text] [Related]
28. A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.
Gabitzsch ES; Xu Y; Yoshida LH; Balint J; Gayle RB; Amalfitano A; Jones FR
Immunol Lett; 2009 Jan; 122(1):44-51. PubMed ID: 19073216
[TBL] [Abstract][Full Text] [Related]
29. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
[TBL] [Abstract][Full Text] [Related]
30. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of control of acute Friend virus infection by CD4+ T helper cells and their functional impairment by regulatory T cells.
Nair SR; Zelinskyy G; Schimmer S; Gerlach N; Kassiotis G; Dittmer U
J Gen Virol; 2010 Feb; 91(Pt 2):440-51. PubMed ID: 19828756
[TBL] [Abstract][Full Text] [Related]
32. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
[TBL] [Abstract][Full Text] [Related]
33. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
[TBL] [Abstract][Full Text] [Related]
35. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice.
Maamary J; Array F; Gao Q; García-Sastre A; Steinman RM; Palese P; Nchinda G
J Virol; 2011 Mar; 85(5):2235-46. PubMed ID: 21159873
[TBL] [Abstract][Full Text] [Related]
36. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.
Miyazawa M; Nishio J; Chesebro B
J Virol; 1992 Jul; 66(7):4497-507. PubMed ID: 1534853
[TBL] [Abstract][Full Text] [Related]
37. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
[TBL] [Abstract][Full Text] [Related]
38. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
39. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
Ruan KS; Lilly F
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
[TBL] [Abstract][Full Text] [Related]
40. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
